A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's disease is described in Nature Medicine. This protein signature may improve the ...

Fighting Alzheimer’s disease is a race against time. By the time most patients are diagnosed and treated, their cognitive symptoms have already advanced significantly. New research, though, pinpoints ...

A large team of neuroscientists, biochemists and Alzheimer's specialists affiliated with institutions in the U.S. and Iceland has created a protein map to look for patterns in cerebrospinal fluid that ...

Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and therapeutic targets that may unlock advancements in Alzheimer’s diagnosis and care. Study: ...

Share on Pinterest A protein found in cerebrospinal fluid may help predict cognitive impairment. Westend61/Getty Images New research investigated the potential of NPTX2, a protein found in the fluid ...

Cerebrospinal fluid (CSF) biomarkers have become indispensable tools in the diagnosis, monitoring and mechanistic understanding of neurodegenerative diseases. By analysing proteins, peptides and other ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

Eisai Co., Ltd. today announced the latest findings on etalanetug (development code: E2814) showed that this investigational ...

It was a shot in the dark — or at best, a dimly lit room: injecting a mouse with a little bit of spinal cord fluid from someone with the most common form of amyotrophic lateral sclerosis, or ALS. Then ...

Summary: A new study demonstrates that the BCG vaccine actively remodels the immune environment surrounding the human brain and spinal cord. By tracking older adults over 12 months, the research team ...